Industry: Chemical & Material
Published Date: 2025-05-29
Pages: 94 Pages
Report ld: 4746698
Request Sample
Customized Report
Recombinant Homocysteine Methyltransferase Market Size(US$)

CAGR 2025-2031
6.6%
Market Size,2031
USD 397
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Recombinant Homocysteine Methyltransferase was valued at US$ 241 million in the year 2024 and is projected to reach a revised size of US$ 397 million by 2031, growing at a CAGR of 6.6% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Recombinant Homocysteine Methyltransferase competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Recombinant homocysteine methyltransferase is a key metabolic enzyme expressed through genetic engineering technology. It catalyzes the methylation of homocysteine to produce methionine and participates in the folate cycle and methylation reaction. This enzyme plays an important role in the pathological mechanism of cardiovascular disease, neurodegenerative diseases and birth defects, and is widely used in in vitro diagnostic reagents, drug development and scientific research. Recombinant RHMT has high purity, high activity and stability, and is usually stored in lyophilized powder or liquid form. It must meet GMP standards to meet clinical and industrial needs.
North American market for Recombinant Homocysteine Methyltransferase is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Recombinant Homocysteine Methyltransferase is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Recombinant Homocysteine Methyltransferase include Creative Enzymes, Biomatik, Gentaur, ZEYE, R&D Systems, KinesisDx, Seebio, DESHENG MATERIALS, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Recombinant Homocysteine Methyltransferase, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Homocysteine Methyltransferase.
The Recombinant Homocysteine Methyltransferase market size, estimations, and forecasts are provided in terms of output/shipments (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Homocysteine Methyltransferase market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Homocysteine Methyltransferase manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Creative Enzymes
Biomatik
Gentaur
ZEYE
R&D Systems
KinesisDx
Seebio
DESHENG MATERIALS
Segment by Type
Monomeric Enzymes
Polymeric Enzymes
Segment by Application
Medical Field
Scientific Research Field
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Homocysteine Methyltransferase manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Recombinant Homocysteine Methyltransferase by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Recombinant Homocysteine Methyltransferase in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Recombinant Homocysteine Methyltransferase Market Overview
1.1 Product Definition
1.2 Recombinant Homocysteine Methyltransferase by Type
1.2.1 Global Recombinant Homocysteine Methyltransferase Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Monomeric Enzymes
1.2.3 Polymeric Enzymes
1.3 Recombinant Homocysteine Methyltransferase by Application
1.3.1 Global Recombinant Homocysteine Methyltransferase Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Medical Field
1.3.3 Scientific Research Field
1.4 Global Market Growth Prospects
1.4.1 Global Recombinant Homocysteine Methyltransferase Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Recombinant Homocysteine Methyltransferase Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Recombinant Homocysteine Methyltransferase Production Estimates and Forecasts (2020-2031)
1.4.4 Global Recombinant Homocysteine Methyltransferase Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Recombinant Homocysteine Methyltransferase Production Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant Homocysteine Methyltransferase Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Recombinant Homocysteine Methyltransferase, Industry Ranking, 2023 VS 2024
2.4 Global Recombinant Homocysteine Methyltransferase Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Recombinant Homocysteine Methyltransferase Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Recombinant Homocysteine Methyltransferase, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Recombinant Homocysteine Methyltransferase, Product Offered and Application
2.8 Global Key Manufacturers of Recombinant Homocysteine Methyltransferase, Date of Enter into This Industry
2.9 Recombinant Homocysteine Methyltransferase Market Competitive Situation and Trends
2.9.1 Recombinant Homocysteine Methyltransferase Market Concentration Rate
2.9.2 Global 5 and 10 Largest Recombinant Homocysteine Methyltransferase Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Recombinant Homocysteine Methyltransferase Production by Region
3.1 Global Recombinant Homocysteine Methyltransferase Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Recombinant Homocysteine Methyltransferase Production Value by Region (2020-2031)
3.2.1 Global Recombinant Homocysteine Methyltransferase Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Recombinant Homocysteine Methyltransferase by Region (2026-2031)
3.3 Global Recombinant Homocysteine Methyltransferase Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Recombinant Homocysteine Methyltransferase Production Volume by Region (2020-2031)
3.4.1 Global Recombinant Homocysteine Methyltransferase Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Recombinant Homocysteine Methyltransferase by Region (2026-2031)
3.5 Global Recombinant Homocysteine Methyltransferase Market Price Analysis by Region (2020-2025)
3.6 Global Recombinant Homocysteine Methyltransferase Production and Value, Year-over-Year Growth
3.6.1 North America Recombinant Homocysteine Methyltransferase Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Recombinant Homocysteine Methyltransferase Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Recombinant Homocysteine Methyltransferase Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Recombinant Homocysteine Methyltransferase Production Value Estimates and Forecasts (2020-2031)
4 Recombinant Homocysteine Methyltransferase Consumption by Region
4.1 Global Recombinant Homocysteine Methyltransferase Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Recombinant Homocysteine Methyltransferase Consumption by Region (2020-2031)
4.2.1 Global Recombinant Homocysteine Methyltransferase Consumption by Region (2020-2025)
4.2.2 Global Recombinant Homocysteine Methyltransferase Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Recombinant Homocysteine Methyltransferase Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Recombinant Homocysteine Methyltransferase Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Recombinant Homocysteine Methyltransferase Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Recombinant Homocysteine Methyltransferase Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Recombinant Homocysteine Methyltransferase Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Recombinant Homocysteine Methyltransferase Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Recombinant Homocysteine Methyltransferase Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Recombinant Homocysteine Methyltransferase Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Recombinant Homocysteine Methyltransferase Production by Type (2020-2031)
5.1.1 Global Recombinant Homocysteine Methyltransferase Production by Type (2020-2025)
5.1.2 Global Recombinant Homocysteine Methyltransferase Production by Type (2026-2031)
5.1.3 Global Recombinant Homocysteine Methyltransferase Production Market Share by Type (2020-2031)
5.2 Global Recombinant Homocysteine Methyltransferase Production Value by Type (2020-2031)
5.2.1 Global Recombinant Homocysteine Methyltransferase Production Value by Type (2020-2025)
5.2.2 Global Recombinant Homocysteine Methyltransferase Production Value by Type (2026-2031)
5.2.3 Global Recombinant Homocysteine Methyltransferase Production Value Market Share by Type (2020-2031)
5.3 Global Recombinant Homocysteine Methyltransferase Price by Type (2020-2031)
6 Segment by Application
6.1 Global Recombinant Homocysteine Methyltransferase Production by Application (2020-2031)
6.1.1 Global Recombinant Homocysteine Methyltransferase Production by Application (2020-2025)
6.1.2 Global Recombinant Homocysteine Methyltransferase Production by Application (2026-2031)
6.1.3 Global Recombinant Homocysteine Methyltransferase Production Market Share by Application (2020-2031)
6.2 Global Recombinant Homocysteine Methyltransferase Production Value by Application (2020-2031)
6.2.1 Global Recombinant Homocysteine Methyltransferase Production Value by Application (2020-2025)
6.2.2 Global Recombinant Homocysteine Methyltransferase Production Value by Application (2026-2031)
6.2.3 Global Recombinant Homocysteine Methyltransferase Production Value Market Share by Application (2020-2031)
6.3 Global Recombinant Homocysteine Methyltransferase Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Creative Enzymes
7.1.1 Creative Enzymes Recombinant Homocysteine Methyltransferase Company Information
7.1.2 Creative Enzymes Recombinant Homocysteine Methyltransferase Product Portfolio
7.1.3 Creative Enzymes Recombinant Homocysteine Methyltransferase Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Creative Enzymes Main Business and Markets Served
7.1.5 Creative Enzymes Recent Developments/Updates
7.2 Biomatik
7.2.1 Biomatik Recombinant Homocysteine Methyltransferase Company Information
7.2.2 Biomatik Recombinant Homocysteine Methyltransferase Product Portfolio
7.2.3 Biomatik Recombinant Homocysteine Methyltransferase Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Biomatik Main Business and Markets Served
7.2.5 Biomatik Recent Developments/Updates
7.3 Gentaur
7.3.1 Gentaur Recombinant Homocysteine Methyltransferase Company Information
7.3.2 Gentaur Recombinant Homocysteine Methyltransferase Product Portfolio
7.3.3 Gentaur Recombinant Homocysteine Methyltransferase Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Gentaur Main Business and Markets Served
7.3.5 Gentaur Recent Developments/Updates
7.4 ZEYE
7.4.1 ZEYE Recombinant Homocysteine Methyltransferase Company Information
7.4.2 ZEYE Recombinant Homocysteine Methyltransferase Product Portfolio
7.4.3 ZEYE Recombinant Homocysteine Methyltransferase Production, Value, Price and Gross Margin (2020-2025)
7.4.4 ZEYE Main Business and Markets Served
7.4.5 ZEYE Recent Developments/Updates
7.5 R&D Systems
7.5.1 R&D Systems Recombinant Homocysteine Methyltransferase Company Information
7.5.2 R&D Systems Recombinant Homocysteine Methyltransferase Product Portfolio
7.5.3 R&D Systems Recombinant Homocysteine Methyltransferase Production, Value, Price and Gross Margin (2020-2025)
7.5.4 R&D Systems Main Business and Markets Served
7.5.5 R&D Systems Recent Developments/Updates
7.6 KinesisDx
7.6.1 KinesisDx Recombinant Homocysteine Methyltransferase Company Information
7.6.2 KinesisDx Recombinant Homocysteine Methyltransferase Product Portfolio
7.6.3 KinesisDx Recombinant Homocysteine Methyltransferase Production, Value, Price and Gross Margin (2020-2025)
7.6.4 KinesisDx Main Business and Markets Served
7.6.5 KinesisDx Recent Developments/Updates
7.7 Seebio
7.7.1 Seebio Recombinant Homocysteine Methyltransferase Company Information
7.7.2 Seebio Recombinant Homocysteine Methyltransferase Product Portfolio
7.7.3 Seebio Recombinant Homocysteine Methyltransferase Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Seebio Main Business and Markets Served
7.7.5 Seebio Recent Developments/Updates
7.8 DESHENG MATERIALS
7.8.1 DESHENG MATERIALS Recombinant Homocysteine Methyltransferase Company Information
7.8.2 DESHENG MATERIALS Recombinant Homocysteine Methyltransferase Product Portfolio
7.8.3 DESHENG MATERIALS Recombinant Homocysteine Methyltransferase Production, Value, Price and Gross Margin (2020-2025)
7.8.4 DESHENG MATERIALS Main Business and Markets Served
7.8.5 DESHENG MATERIALS Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Recombinant Homocysteine Methyltransferase Industry Chain Analysis
8.2 Recombinant Homocysteine Methyltransferase Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Recombinant Homocysteine Methyltransferase Production Mode & Process Analysis
8.4 Recombinant Homocysteine Methyltransferase Sales and Marketing
8.4.1 Recombinant Homocysteine Methyltransferase Sales Channels
8.4.2 Recombinant Homocysteine Methyltransferase Distributors
8.5 Recombinant Homocysteine Methyltransferase Customer Analysis
9 Recombinant Homocysteine Methyltransferase Market Dynamics
9.1 Recombinant Homocysteine Methyltransferase Industry Trends
9.2 Recombinant Homocysteine Methyltransferase Market Drivers
9.3 Recombinant Homocysteine Methyltransferase Market Challenges
9.4 Recombinant Homocysteine Methyltransferase Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Recombinant Homocysteine Methyltransferase market is projected to grow from US$ 270 million in 2025 to US$ 421 million by 2032, at a CAGR of 6.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-11
Pages: 148
USD 4900.00
(Single User License)
The global Recombinant Homocysteine Methyltransferase market was valued at US$ 270 million in 2025 and is anticipated to reach US$ 421 million by 2032, at a CAGR of 6.6% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 133
USD 2900.00
(Single User License)
The global Recombinant Homocysteine Methyltransferase market size was US$ 270 million in 2025 and is forecast to reach a readjusted size of US$ 421 million by 2032 with a CAGR of 6.6% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 77
USD 4250.00
(Single User License)
The global market for Recombinant Homocysteine Methyltransferase was estimated to be worth US$ 270 million in 2025 and is projected to reach US$ 421 million, growing at a CAGR of 6.6% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 109
USD 3950.00
(Single User License)
The global market for Recombinant Homocysteine Methyltransferase was estimated to be worth US$ 241 million in 2024 and is forecast to a readjusted size of US$ 397 million by 2031 with a CAGR of 6.6% during the forecast period 2025-2031.
Published Date: 2025-05-29
Pages: 98
USD 3950.00
(Single User License)
The global Recombinant Homocysteine Methyltransferase market size was US$ 241 million in 2024 and is forecast to a readjusted size of US$ 397 million by 2031 with a CAGR of 6.6% during the forecast period 2025-2031.
Published Date: 2025-05-29
Pages: 79
USD 4250.00
(Single User License)
The global Recombinant Homocysteine Methyltransferase market is projected to grow from US$ 270 million in 2025 to US$ 397 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.6% during the forecast period.
Published Date: 2025-05-29
Pages: 138
USD 4900.00
(Single User License)
The global Recombinant Homocysteine Methyltransferase market is projected to grow from US$ 270 million in 2025 to US$ 421 million by 2032, at a CAGR of 6.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-11
Pages: 148
The global Recombinant Homocysteine Methyltransferase market was valued at US$ 270 million in 2025 and is anticipated to reach US$ 421 million by 2032, at a CAGR of 6.6% from 2026 to 2032.
Published: 2026-03-11
Pages: 133
The global Recombinant Homocysteine Methyltransferase market size was US$ 270 million in 2025 and is forecast to reach a readjusted size of US$ 421 million by 2032 with a CAGR of 6.6% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 77
The global market for Recombinant Homocysteine Methyltransferase was estimated to be worth US$ 270 million in 2025 and is projected to reach US$ 421 million, growing at a CAGR of 6.6% from 2026 to 2032.
Published: 2026-03-09
Pages: 109
The global market for Recombinant Homocysteine Methyltransferase was estimated to be worth US$ 241 million in 2024 and is forecast to a readjusted size of US$ 397 million by 2031 with a CAGR of 6.6% during the forecast period 2025-2031.
Published: 2025-05-29
Pages: 98
The global Recombinant Homocysteine Methyltransferase market size was US$ 241 million in 2024 and is forecast to a readjusted size of US$ 397 million by 2031 with a CAGR of 6.6% during the forecast period 2025-2031.
Published: 2025-05-29
Pages: 79
The global Recombinant Homocysteine Methyltransferase market is projected to grow from US$ 270 million in 2025 to US$ 397 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.6% during the forecast period.
Published: 2025-05-29
Pages: 138
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now